The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist

Eur J Pharmacol. 1985 Dec 3;118(3):321-9. doi: 10.1016/0014-2999(85)90143-8.

Abstract

The alpha-adrenoceptor activity of fenoldopam was evaluated in three different in vitro tissue preparations. In rabbit isolated aortic rings fenoldopam displayed weak alpha 1-adrenoceptor antagonist activity (-log KB = 5.41) and displayed no alpha 1-adrenoceptor agonist activity. In contrast, fenoldopam demonstrated moderately potent antagonist properties at the alpha 2-adrenoceptor in two other tissue preparations. In in vitro model systems used for the characterization of alpha 2-adrenoceptors, fenoldopam competitively antagonized the effects of the alpha 2-adrenoceptor agonist B-HT 920. In the dog isolated saphenous vein and in the isolated field-stimulated guinea-pig ileum, fenoldopam antagonized the effects of B-HT 920 with -log KB values of 7.78 and 7.60, respectively. These data indicate that in addition to being an agonist at DA1 receptors, fenoldopam is also a relatively selective antagonist at alpha 2-adrenoceptors.

MeSH terms

  • Adrenergic alpha-Agonists*
  • Animals
  • Aorta, Thoracic / drug effects
  • Benzazepines / pharmacology*
  • Dogs
  • Electric Stimulation
  • Female
  • Fenoldopam
  • Guinea Pigs
  • Ileum / drug effects
  • In Vitro Techniques
  • Male
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Rabbits
  • Receptors, Dopamine / drug effects*
  • Saphenous Vein / drug effects
  • Spleen / drug effects
  • Vasodilator Agents / pharmacology*

Substances

  • Adrenergic alpha-Agonists
  • Benzazepines
  • Receptors, Dopamine
  • Vasodilator Agents
  • Fenoldopam